Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
瑞士一项针对类风湿性关节炎患者的观察性队列研究比较了抗肿瘤坏死因子药物、作用机制不同的生物制剂和托法替尼的疗效
期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2020-001174
Finckh, A; Tellenbach, C; Herzog, L; Scherer, A; Moeller, B; Ciurea, A; von Muehlenen, I; Gabay, C; Kyburz, D; Brulhart, L; Müller, R; Hasler, P; Zufferey, P